🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the statistical non inferiority of the combination of latano...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-07
Trial ID
NCT00140049
This study was designed to compare the 24-hour efficacy on intra ocular pre...
Status
Completed
Location
University Eye Clinic
Start Date
2002-01
Trial ID
NCT01655758
Treatments Being Tested
The objective of the study is to assess the efficacy and safety of T2347 (L...
Status
Completed
Location
Laboratoires Thea
Start Date
2014-12
Trial ID
NCT02278614
The study investigated the 24-hour efficacy and ocular surface health with ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02802137
Treatments Being Tested
To determine the predictive factors of a positive response to latanoprost 0...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00230763
Treatments Being Tested
The ideal dosing for preservative-free tafluprost/timolol fixed combination...
Status
Completed
Location
1st University Department of Ophthalmology
Start Date
2017-01
Trial ID
NCT03612817
Treatments Being Tested
The primary objective of this crossover trial is to compare the 3-month, me...
Status
Completed
Location
Glaucoma Unit, 1st University Department of Ophthalmology
Start Date
2012-01
Trial ID
NCT01779284
Treatments Being Tested
Safety and efficacy study comparing between fixed combination latanoprost-t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
1997-07
Trial ID
NCT00800267
Treatments Being Tested
To prove the non-inferiority of the fixed timolol-dorzolamide combination (...
Status
Completed
Location
Seoul St. Mary's hospital
Start Date
2011-03
Trial ID
NCT01175902
Treatments Being Tested
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560